Background: A scoping review was conducted to examine the breadth of evidence related to
telehealth innovations being utilized in the treatment of opioid use disorder (OUD) with …

Background Telemedicine-delivered buprenorphine (tele-buprenorphine) can potentially
increase access to buprenorphine for patients with opioid use disorder (OUD), especially …

Introduction Opioid use disorder (OUD) is a debilitating illness that remains a serious public
health issue in the United States. Use of telemedicine to deliver m edications for the …

Objective The COVID-19 pandemic has transformed care delivery for patients with opioid
use disorder (OUD); however, little is known about the experiences of front-line clinicians in …

Federal regulatory changes during the COVID-19 pandemic allow buprenorphine to be
prescribed without an initial in-person evaluation. Prior to COVID-19, numerous barriers …

Background and Objectives The opioid epidemic in the United States has resulted in a
public health emergency. Medication‐assisted treatment (MAT) with methadone and …

Objective To understand clinician use of and opinions about telemedicine for opioid use
disorder (tele-OUD) during the COVID-19 pandemic. Methods An electronic national survey …

This report builds on a previous study that describes the collaboration between an urban
academic medical center and a rural drug treatment center, the goal of which is to provide …

Background Changes in federal policy during the COVID-19 pandemic allowing for the use
of telemedicine to treat opioid use disorder (OUD) have facilitated innovative strategies to …

Background The majority of individuals with opioid use disorder (OUD) face access barriers
to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United …